Vicki L. Sato - 18 Jun 2025 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Reporting relationship
Director
Issuer ticker
ALLO
Reported as of
18 Jun 2025
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 Jun 2025, 21:04:04 UTC
Prior SEC filing
02 Jun 2025
Next SEC filing
02 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Earl Douglas, Attorney-in-Fact

Key filing fact

Vicki L. Sato filed Form 4 for Allogene Therapeutics, Inc. (ALLO) on 23 Jun 2025.

Key facts

  • This page summarizes Vicki L. Sato's Form 4 filing for Allogene Therapeutics, Inc. (ALLO).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 23 Jun 2025, 21:04.

Change

  • Previous filing in this sequence was filed on 02 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001197020 Primary reporting owner

SATO VICKI L

Relationship
Director
Address
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Signature
/s/Earl Douglas, Attorney-in-Fact
Signature date
20 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALLO transaction Derivative

Stock Option (Right to buy)

Award

Transaction value
$0
Shares
+144,400
Change %
Price
$0.000000
Shares after
144,400
Date
18 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
144,400
Exercise price
$1.29
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Vesting in 12 equal monthly installments.

SEC remarks

Exhibits: Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .